Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07303517 · ClinicalTrials.gov registry record

AI-Driven Consent Simplification Study

A clinical trial of Communication and Informed Consent, sponsored by University of California, Los Angeles.

Recruiting
Registry status
230
Enrollment target
1
Study location

NCT07303517: Recruiting study of Communication and Informed Consent, sponsored by University of California, Los Angeles.

NCT07303517 is a study of Communication and Informed Consent that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 230 participants, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07303517, a study of Communication and Informed Consent, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
230 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses. Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving informed consent form (ICF) comprehension can lead to more informed and willing participation in clinical studies. This improved understanding may result in higher enrollment rates, better subject retention, and more accurate data collection as individuals will have a clearer understanding of study procedures and risks.

Primary Outcome

The QUIC measures knowledge recall. The summed score of 10 knowledge items comprising key concepts of informed consent will be calculated. The scores range between 0 and 22 with higher scores indicating higher knowledge.

Conditions Studied

Communication Informed Consent Disclosure Comprehension

Interventions

  • BEHAVIORAL Original ICF
  • BEHAVIORAL AI Simplified ICF
  • BEHAVIORAL Podcast - Original ICF
  • BEHAVIORAL Podcast - Simplified ICF

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2026-01-08
Est. Completion 2026-12-01
University of California, Los Angeles

897 total trials

What NCT07303517 shows while recruiting

NCT07303517 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (84% lower).

The record links to 4 conditions, with Communication appearing as the primary indexed condition, and to 4 interventions - of which Original ICF is the first listed.

NCT07303517 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07303517 about?

NCT07303517 is a clinical study titled "AI-Driven Consent Simplification Study". The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large la...

What is the current status of trial NCT07303517?

This trial is currently recruiting. The enrollment target is 230 participants. The study started on 2026-01-08. Estimated completion is 2026-12-01.

What conditions does trial NCT07303517 study?

This clinical trial studies the following conditions: Communication, Informed Consent, Disclosure, Comprehension.

What interventions are being tested in trial NCT07303517?

The interventions under investigation include: Original ICF (BEHAVIORAL), AI Simplified ICF (BEHAVIORAL), Podcast - Original ICF (BEHAVIORAL), Podcast - Simplified ICF (BEHAVIORAL).

Who is sponsoring clinical trial NCT07303517?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07303517 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07303517's enrollment target sits among peer trials

230 23rd of 34 higher than 12 of 34 other Communication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07303517

Source: ClinicalTrials.gov NCT07303517, the US trial registry maintained by the National Library of Medicine. NCT07303517 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.